New York- Presbyterian Hospital

New York-Presbyterian Hospital was formed in 1998 with the merger of New York Hospital and Presbyterian Hospital in New York City. New York-Presbyterian is the university hospital for Cornell and Columbia universities. New York-Presbyterian is actually five campuses. New York-Presbyterian Hospital/Columbia University Medical Center, New York-Presbyterian Hospital/Weill Cornell Medical Center, New-York Presbyterian Hospital/The Allen Pavilion, Morgan Stanley's Children's Hospital, New York-Presbyterian Hospital Westchester Division. New York-Presbyterian is rated as one of the largest medical centers in the world and is consistently rated in the top tier of teaching hospitals, research in complex diseases, cutting edge surgery and excellence in physician training.

Over the past decade, research in the field of epigenetics has revealed that chemically modified bases are abundant components of the human genome and has forced us to abandon the notion we've had since high school genetics ...

Researchers at Weill Cornell Medical College have shown that it is possible to immunize mammals to control fertility. They say their technique could possibly be used on other mammals -- including humans -- because fertility ...

In the longest study of its kind, bariatric surgery has been shown to reduce the risk of heart attack and stroke in patients with diabetes. These results and other groundbreaking research were presented at the 2nd World Congress ...

Bariatric surgery should be considered earlier in the treatment of eligible patients to help stem the serious complications that can result from diabetes, according to an International Diabetes Federation (IDF) position statement ...

A new study published by researchers at Weill Cornell Medical College and the University of California, Davis, foresees improvements in patient outcomes after a major earthquake through more effective use of information technology. ...

A gene therapy called NLX-P101 dramatically reduces movement impairment in Parkinson's patients, according to results of a Phase 2 study published today in the journal Lancet Neurology. The approach introduces a gene into t ...

During a regular annual physical exam, blood is usually drawn to check the health of a person's heart, kidneys and liver. Now, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say a blood test that ...

Using a sophisticated imaging test to probe for higher-level cognitive functioning in severely brain-injured patients provides a window into consciousness -- but the view it presents is one that is blurred in fascinating ...

A new clinical trial at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is among the first to test surgery specifically for Type 2 diabetes. The aim of the study is to understand whether surgery can control diabetes, ...

For the first time, researchers have laid bare the full genetic blueprint of multiple prostate tumors, uncovering alterations that have never before been detected and offering a deep view of the genetic missteps that underlie ...

There is new hope for people with acute myelogenous leukemia (AML), a fast-growing cancer of the blood and bone marrow. Research led by Weill Cornell Medical College and published today in the online edition of the journal ...

An experimental immunotherapy may someday become the newest weapon against lung cancer. Physician-scientists from Weill Cornell Medical College and Columbia University Medical Center are enrolling patients with non-small ...

A hormone made by the body may be a potential therapeutic tool for the treatment of two anemic blood disorders -- beta-thalassemia and hemochromatosis. The new research was led by scientists at Weill Cornell Medical College ...